Clinical trial BHS-TC11-01
A Phase II study to assess the safety and the efficacy of extracorporeal photopheresis using the Theraflex ECPTM (Macropharma) for patients with refractory chronic GVHD
Cancers | |
---|---|
Organ | NA |
Trial status | Trial open for recruitment |
Investigator | |
Trial type |
Interventional without experimental drug
|
Phase | Trial phase 2 |
Academic trial | Oui |
Sponsor | BHS |
BECT Identifier | B079201318627 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03083574 |
Inclusion criteria | chronic GVHD - already been treated with first-line systemic therapy for at least 1 month - refractoriness or contraindication/intolerance to current therapy |
Last update |